Follistatin 315 1 mg Peptide Sciences

£110.00

SKU: PEP-BO-0632 Categories: ,

Description

Product Description: Follistatin 315 1 mg Peptide Sciences

Are you a bodybuilder looking to enhance your muscle growth and performance? Look no further than Follistatin 315 1 mg from Peptide Sciences. This high-quality peptide offers a range of benefits that can help you achieve your fitness goals effectively and safely.

Specific Details and Features

  • Quantity: 1 mg
  • Manufacturer: Peptide Sciences
  • Purity: 99%+
  • Form: Lyophilized powder
  • Sequence: Tyr-Gln-Pro-Pro-Ser-Thr-Asn-Lys-Asn-Thr-Lys-Ser-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-Asn-Lys-Gly-Gln-Gln-Thr-Pro-Lys-Pro-Thr-Gly-Ser-Thr-Lys-

Additional information

Active ingredient

Peptide

Active ingredient, mg

1

Form der Produktion

Fläschchen

1 bottle, ml

10

Fläschchen pro Packung, Stk.

1

Hersteller

Peptide Sciences

Reviews

There are no reviews yet.

Be the first to review “Follistatin 315 1 mg Peptide Sciences”

Your email address will not be published. Required fields are marked *